Abstract
Lower extremity peripheral artery disease (PAD) now affects approximately 200 million men and women worldwide and 8 million people in the United States. The prevalence of PAD increases with older age. PAD will be increasingly common as the population lives longer with chronic disease. Although the most classic symptom of PAD is intermittent claudication, most people with PAD do not have classic intermittent claudication, and many people with PAD report no exertional leg symptoms, in part because people with PAD have restricted their activity to avoid leg symptoms. For these reasons, PAD is frequently underdiagnosed. The therapeutic approach to PAD consists of medical therapies to prevent cardiovascular events and exercise interventions to improve walking ability and prevent mobility loss.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40.
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.
McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–606.
McDermott MM, Applegate WB, Bonds DE, Buford TW, Church T, Espeland MA, et al. Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study. J Am Heart Assoc. 2013;2(6):e000257.
McDermott MM. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116(9):1540–50.
McDermott MM, Liu K, Criqui MH, Ruth K, Goff D, Saad MF, et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2005;162(1):33–41.
Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-ethnic study of atherosclerosis). J Am Coll Cardiol. 2010;56(18):1506–12.
Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509–26.
Allison MA, Ho E, Denenberg JO, Langer RD, Newman AB, Fabsitz RR, et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med. 2007;32(4):328–33.
Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh artery study. Am J Epidemiol. 1992;135(4):331–40.
Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk. 1994;1(4):333–9.
Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease. JAMA. 2012;308(16):1660–7.
Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24(8):1433–7.
Haltmayer M, Mueller T, Horvath W, Luft C, Poelz W, Haidinger D. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol. 2001;20(3):200–7.
Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a measure of atherosclerosis in the Cardiovascular Health Study(CHS) Collaborative Research Group. Circulation. 1993;88(3):837–45.
McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the Women’s Health and Aging Study. Circulation. 2000;101(9):1007–12.
Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645–58.
Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996;1(1):65–71.
McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med. 2002;136(12):873–83.
Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890–909.
Lijmer JG, Hunink MGM, van den Dungen JL, Smit AJ. ROC analyses of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol. 1996;22(4):391–8.
Guo X, Li J, Paang W, Zhao M, Luo Y, Sun Y, et al. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ J. 2008;72(4):605–10.
Ouriel K, McDonnell AE, Metz CE, Zarinss CK. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982;91(6):686–93.
McDermott MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial pressure, and lower extremity functioning in peripheral arterial disease. J Vasc Surg. 2000;32(6):1164–71.
Nead KT, Cooke JP, Olin JW, Leeper NJ. Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol. 2013;62(6):553–9.
Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.
McDermott MM, Liu K, Greenland P, Guralnik JM, Criqui MH, Chan C, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004;292(4):453–61.
McDermott MM, Guralnik JM, Tian L, Liu K, Ferrucci L, Liao Y, et al. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol. 2009;53(12):1056–62.
McDermott MM, Ferrucci L, Liu K, Guralnik JM, Tian L, Liao Y, et al. Leg symptom categories and rates of mobility decline in peripheral artery disease. J Am Geriatr Soc. 2010;58(7):1256–62.
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients with peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135:e686–785.
Hess CN, Hiatt WR. Antithrombotic therapy for peripheral artery disease in 2018. JAMA. 2018;319(22):2329–30.
McDermott MM. Exercise rehabilitation for peripheral artery disease: a review. J Cardiopulm Rehabil Prev. 2018;38(2):63–9.
McDermott MM. Medical management of functional impairment in peripheral artery disease: a review. Prog Cardiovasc Dis. 2018;60(6):586–92.
McDermott MM. Exercise training for intermittent claudication. J Vasc Surg. 2017;66(5):1612–20.
Harwood AE, Smith GE, Cayton T, Broadbent E, Chetter IC. A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication. Ann Vasc Surg. 2016;34:280–9.
McDermott MM, Kibbe MR, Guralnik JM, Ferrucci L, Criqui MH, Domanchuk K, et al. Durability of benefits from supervised treadmill exercise in patients with peripheral artery disease. J Am Heart Assoc. 2019;8(1):e009380.
McDermott MM, Spring B, Berger JS, Treat-Jacobson D, Conte MS, Creager MA, et al. Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR Randomized Clinical Trial. JAMA. 2018;319(16):1665–76.
McDermott MM, Ferrucci L, Tian L, Guralnik JM, Lloyd-Jones D, Kibbe MR, et al. Effect of granulocyte-macrophage colony-stimulating factor with or without supervised exercise on walking performance in patients with peripheral artery disease: the PROPEL randomized clinical trial. JAMA. 2017;318(21):2089–98.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
McDermott, M.M. (2020). Peripheral Artery Disease: An Overview. In: Yuan, C., Hatsukami, T., Mossa-Basha, M. (eds) Vessel Based Imaging Techniques . Springer, Cham. https://doi.org/10.1007/978-3-030-25249-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-25249-6_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25248-9
Online ISBN: 978-3-030-25249-6
eBook Packages: MedicineMedicine (R0)